. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Clinical Trials, Phase III as TopicGlioblastoma/drug therapyGlioblastoma/mortalityGlioblastoma/therapyHumansRandomized Controlled Trials as TopicSurvival RateTemozolomide/therapeutic useWearable Electronic Devices
Substances: See more » Temozolomide
Year: 2017 PMID: 28880388 DOI: 10.1002/cncr.30963
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860